Clinical Trials Browser

Phase 1/2 × Cardiotoxicity × 1 year × Clear all

NCT04737265 2025-07-03

NTproBNP-Guide

Phase 1/2 Completed

Breast Neoplasms, Heart Failure, Lymphoma, Cardiomyopathies, Cardiotoxicity